{"transactions":[{"id":869970,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63540,"kind":"person","name":"Exton Michael","position":1,"cik":"0002029249","reported_name":"Exton Michael","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-03T12:15:34.000Z","date":"2026-02-28","kind":"exercise","planned":false,"acquired":false,"shares":503263,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":1006527,"derivative":{"underlying":"Common Stock","underlying_shares":503263},"source":{"system":"sec-edgar","filing":"0001062822-26-000034","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000034/form4.xml","form_type":"4"}},{"id":869969,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63540,"kind":"person","name":"Exton Michael","position":1,"cik":"0002029249","reported_name":"Exton Michael","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-03T12:15:34.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":204831,"price":1.47,"value":301101.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":298432,"source":{"system":"sec-edgar","filing":"0001062822-26-000034","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000034/form4.xml","form_type":"4"}},{"id":869968,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63540,"kind":"person","name":"Exton Michael","position":1,"cik":"0002029249","reported_name":"Exton Michael","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-03T12:15:34.000Z","date":"2026-02-28","kind":"exercise","planned":false,"acquired":true,"shares":503263,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":503263,"source":{"system":"sec-edgar","filing":"0001062822-26-000034","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000034/form4.xml","form_type":"4"}},{"id":901902,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63540,"kind":"person","name":"Exton Michael","position":1,"cik":"0002029249","reported_name":"Exton Michael","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-17T21:05:31.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":1293670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":1293670,"derivative":{"exercise_price":1.37,"expiration_date":"2036-02-12","underlying":"Common Stock","underlying_shares":1293670},"source":{"system":"sec-edgar","filing":"0001062822-26-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000019/form4.xml","form_type":"4"}},{"id":901901,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63540,"kind":"person","name":"Exton Michael","position":1,"cik":"0002029249","reported_name":"Exton Michael","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-17T21:05:31.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":862440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":862440,"derivative":{"underlying":"Common Stock","underlying_shares":862440},"source":{"system":"sec-edgar","filing":"0001062822-26-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000019/form4.xml","form_type":"4"}},{"id":1264736,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63540,"kind":"person","name":"Exton Michael","position":1,"cik":"0002029249","reported_name":"Exton Michael","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-18T21:16:42.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":1509790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":1509790,"derivative":{"underlying":"Common Stock","underlying_shares":1509790},"source":{"system":"sec-edgar","filing":"0001127602-25-005209","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225005209/form4.xml","form_type":"4"}},{"id":1264735,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63540,"kind":"person","name":"Exton Michael","position":1,"cik":"0002029249","reported_name":"Exton Michael","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T21:16:42.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":2264690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":2264690,"derivative":{"exercise_price":0.695,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":2264690},"source":{"system":"sec-edgar","filing":"0001127602-25-005209","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225005209/form4.xml","form_type":"4"}},{"id":1458454,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":63540,"kind":"person","name":"Exton Michael","position":1,"cik":"0002029249","reported_name":"Exton Michael","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-08T21:27:00.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":1675000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":1675000,"derivative":{"exercise_price":1.67,"expiration_date":"2034-07-08","underlying":"Common Stock","underlying_shares":1675000},"source":{"system":"sec-edgar","filing":"0001127602-24-020202","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224020202/form4.xml","form_type":"4"}}]}